ADAR anticorps (N-Term)
Aperçu rapide pour ADAR anticorps (N-Term) (ABIN634454)
Antigène
Voir toutes ADAR AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- ADAR antibody was raised against the N terminal of ADAR
-
Purification
- Affinity purified
-
Immunogène
- ADAR antibody was raised using the N terminal of ADAR corresponding to a region with amino acids GEGKATTAHDLSGKLGTPKKEINRVLYSLAKKGKLQKEAGTPPLWKIAVS
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
ADAR Blocking Peptide, (ABIN938614), is also available for use as a blocking control in assays to test for specificity of this ADAR antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ADAR antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- ADAR (Adenosine Deaminase, RNA-Specific (ADAR))
-
Autre désignation
- ADAR
-
Sujet
- ADAR is responsible for RNA editing by site-specific deamination of adenosines. This enzyme destabilizes double stranded RNA through conversion of adenosine to inosine. Mutations in this gene have been associated with dyschromatosis symmetrica hereditaria. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.
-
Poids moléculaire
- 136 kDa (MW of target protein)
-
Pathways
- Protein targeting to Nucleus
Antigène
-